Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0857-2018

Drug recall · May 30, 2018

Lidocaine Patch 5% recall

Why: Failed Stability Specifications

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC 0591-3525-30)

Lots / codes

Carton Lot Number:1147020B Patch (Envelope) Lot Number: 1147020

Quantity
30,382 patches
Company
Teva Pharmaceuticals USA, North Wales, PA
Distribution
United States
Initiated
April 30, 2018 · Voluntary: Firm initiated
Classified
June 11, 2018
Reported
May 30, 2018
Ended
January 14, 2019
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Lidocaine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.